Stocks · Health care · Pharmaceutical Preparations

Erasca, Inc.

ERAS Clue Score37
United States Fiscal year ends December CIK 0001761918 Results filed 11 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Ebun Garner
1 Apr 2026
Chief Legal Officer
Sold after exercise
80,000
$16.40
$1.31M
Shannon Morris
4 Mar 2026
Chief Medical Officer
Sold after exercise
20,000
$15.04
$300.76K
Ebun Garner
7 Jan 2026
General Counsel & Corp. Sec.
Sold after exercise
120,000
$5.59
$670.81K
Alexander W. Casdin
21 May 2024
Director
Buy
80,000
$2.27
$181.92K
Jonathan E Lim
6 Dec 2023
Chairman & CEO
Buy indirect
278,150
$1.72
$478.42K
Valerie Denise Harding Start
6 Dec 2023
Director
Buy indirect
10,000
$1.85
$18.48K
Jonathan E Lim
5 Dec 2023
Chairman & CEO
Buy indirect
721,850
$1.69
$1.22M
Alexander W. Casdin
4 Dec 2023
Director
Buy
30,000
$1.66
$49.79K
Jonathan E Lim
5 Oct 2023
Chairman & CEO
Buy indirect
1,000,000
$2.03
$2.03M
Jonathan E Lim
8 Jun 2023
Chairman & CEO
Buy indirect
100,000
$2.75
$275.00K
Alexander W. Casdin
10 Apr 2023
Director
Buy
20,000
$2.76
$55.23K
Jonathan E Lim
28 Mar 2023
Chairman & CEO
Buy indirect
100,000
$2.84
$284.00K
Jonathan E Lim
10 Jan 2023
Chairman & CEO
Buy indirect
60,000
$3.86
$231.42K
James Arthur Bristol
21 Dec 2022
Director
Buy indirect
20,000
$4.14
$82.80K
Valerie Denise Harding Start
21 Dec 2022
Director
Buy indirect
10,000
$4.64
$46.40K
Alexander W. Casdin
15 Dec 2022
Director
Buy
20,000
$4.87
$97.49K
Jonathan E Lim
14 Dec 2022
Chairman & CEO
Buy indirect
40,000
$4.99
$199.60K
Bihua Chen
13 Dec 2022
Director
Buy indirect
307,692
$6.50
$2.00M
Bihua Chen
10 Aug 2021
Director
Buy indirect
200,000
$22.10
$4.42M
Bihua Chen
26 Jul 2021
Director
Sell indirect
200,000
$18.77
$3.75M
Julie Hambleton
20 Jul 2021
Director
Buy
6,000
$16.00
$96.00K
Pratik S Multani
20 Jul 2021
Director
Buy
6,200
$16.00
$99.20K
Valerie Denise Harding Start
20 Jul 2021
Director
Buy
2,000
$16.00
$32.00K
Ebun Garner
20 Jul 2021
General Counsel
Buy
900
$16.00
$14.40K
Bihua Chen
20 Jul 2021
Director
Buy indirect
950,000
$16.00
$15.20M

What was left out

Form 4 filings counted 108
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 3
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 33,141,456
Sales filed before the plan box existed 1
History held since 20 Jul 2021